Solving the questions regarding 5-aminosalitylate formulation in the treatment of ulcerative colitis.

Authors:
Naganuma M.

Journal:
J Gastroenterol

Publication Year: 2020

DOI:
10.1007/s00535-020-01713-8

PMCID:
PMC7567706

PMID:
32778960

View on PubMed View on PMC View Publisher
Journal Information

Full Title: J Gastroenterol

Abbreviation: J Gastroenterol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Gastroenterology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Clinical development of a blood biomarker using apolipoprotein-A2 isoforms for early detection of p…
Kashiro A; Kobayashi M; Oh T and 23 more (2024) - Transparency Score: 3/6
Mucosal neuroimmune mechanisms in gastro-oesophageal reflux disease (GORD) pathogenesis.
Leech T; Peiris M. (2024) - Transparency Score: 3/6
Risk of gastric adenoma and adenocarcinoma in patients with familial adenomatous polyposis in Japan…
Sasaki K; Kawai K; Nozawa H and 17 more (2024) - Transparency Score: 4/6
Anxiety and behavioral changes in Japanese patients with inflammatory bowel disease due to COVID-19…
Nakase H; Wagatsuma K; Nojima M and 31 more (2023) - Transparency Score: 4/6
Blockade of C5aR1 alleviates liver inflammation and fibrosis in a mouse model of NASH by regulating…
Jiang K; Lu S; Li D and 7 more (2023) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest Makoto Naganuma received commercial research funds from EA Pharma Co., Ltd. and Mochida Pharmaceutical Co., Ltd., and received lecture fees from Takeda Pharmaceutical Co., Ltd. and Pfeizer Co., Ltd."

Evidence found in paper:

"Funding None."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025